CN111073925B - High-efficiency polypeptide-polypeptide coupling system and method based on disordered protein coupling enzyme - Google Patents
High-efficiency polypeptide-polypeptide coupling system and method based on disordered protein coupling enzyme Download PDFInfo
- Publication number
- CN111073925B CN111073925B CN201910995483.6A CN201910995483A CN111073925B CN 111073925 B CN111073925 B CN 111073925B CN 201910995483 A CN201910995483 A CN 201910995483A CN 111073925 B CN111073925 B CN 111073925B
- Authority
- CN
- China
- Prior art keywords
- protein
- spy
- tag
- enzyme
- coupling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
- C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
- C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
- C12Y105/01—Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
- C12Y105/01003—Dihydrofolate reductase (1.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明公布了一种基于无序蛋白偶联酶的高效多肽‑多肽偶联系统和方法。通过设计拆分蛋白质结构域CnaB2并进行优化,得到三组分体系:谍标签(SpyTag)、BD标签(BDTag)和谍订书机酶(SpyStapler),使得SpyStapler可以催化SpyTag与BDTag之间的偶联反应,并制备含有SpyTag和BDTag两个标签的不同的融合蛋白质并进行偶联或环化反应。基于本发明的多肽‑多肽偶联系统,可以利用基因编码的方式获得纯度高且功能稳定的活性蛋白质;谍订书机酶偶联谍标签和BD标签反应效率高,且反应后部分谍订书机酶脱落,得到的环化产物的偶联部分分子量较小。本发明的蛋白质标签适用于多种功能蛋白质及可以融合表达于蛋白质的任意位置。
The invention discloses an efficient polypeptide-polypeptide coupling system and method based on disordered protein coupling enzymes. By designing and splitting the protein domain CnaB2 and optimizing it, a three-component system is obtained: spy tag (SpyTag), BD tag (BDTag) and spy stapler enzyme (SpyStapler), so that SpyStapler can catalyze the coupling between SpyTag and BDTag. Coupling reaction, and prepare different fusion proteins containing SpyTag and BDTag two tags and carry out coupling or cyclization reaction. Based on the polypeptide-polypeptide coupling system of the present invention, an active protein with high purity and stable function can be obtained by means of gene coding; the reaction efficiency of the spy-stapling machine enzyme-coupled spy-tag and the BD-tag is high, and part of the spy is stapled after the reaction The organic enzyme falls off, and the coupling part of the obtained cyclization product has a smaller molecular weight. The protein tag of the present invention is suitable for a variety of functional proteins and can be fused and expressed at any position of the protein.
Description
技术领域technical field
本发明涉及多肽的偶联技术,特别涉及一种基于无序蛋白偶联酶的多肽-多肽偶联体系,以及基于该体系对蛋白质进行偶联或实现环化的方法。The present invention relates to the coupling technology of polypeptides, in particular to a polypeptide-polypeptide coupling system based on disordered protein coupling enzymes, and a method for coupling or realizing cyclization of proteins based on the system.
背景技术Background technique
多肽/蛋白质标签被广泛应用在蛋白质纯化、蛋白质拓扑工程、生物影像等领域。探连接酶(SnoopLigase)、内含肽(Intein)、分拣酶(Sortase)、蝶豆粘酶(Butelase 1)和天冬酰胺内肽酶(OaAEP1)等蛋白质工具以其高效性、特异性被认为是非常有效的生物多肽偶联方法。Peptide/protein tags are widely used in protein purification, protein topology engineering, biological imaging and other fields. Protein tools such as SnoopLigase, Intein, Sortase, Butelase 1, and Asparagine Endopeptidase (OaAEP1) have been used for their high efficiency and specificity. It is considered to be a very effective biological polypeptide coupling method.
“分子超级胶水”技术的出现提供了一类新的蛋白质标记策略。谍标签(SpyTag)和谍捕手(SpyCatcher)体系、探标签(SnoopTag)和探捕手(SnoopCatcher)体系以及它们的突变体已经证明了“分子胶水”的特异的亲和标记性质。The emergence of "molecular superglue" technology provides a new class of protein labeling strategies. SpyTag and SpyCatcher systems, SnoopTag and SnoopCatcher systems and their mutants have demonstrated the specific affinity tagging properties of "molecular glue".
目前,基于蛋白质结构拆分得到的蛋白质标记工具很少,研究者拆分蛋白质结构域CnaB2得到谍标签(SpyTag)、K标签(KTag)和谍连接酶(SpyLigase),以及拆分蛋白质结构域RrgA得到小探标签(SnoopTagJr)、狗标签(DogTag)和探连接酶(SnoopLigase)。这两个体系需要添加额外的小分子添加剂N-氧化三甲胺(TMAO)或甘油,而且其连接酶的连接效率并不高。目前,特别需要发展高效的基于蛋白质的多肽-多肽偶联酶,特别是那些无需添加剂的高效连接酶体系。At present, there are few protein labeling tools based on protein structure splitting. Researchers split the protein domain CnaB2 to obtain SpyTag, KTag and SpyLigase, and split the protein domain RrgA A small probe tag (SnoopTagJr), a dog tag (DogTag) and a probe ligase (SnoopLigase) were obtained. These two systems require the addition of an additional small molecule additive N-trimethylamine oxide (TMAO) or glycerol, and the ligation efficiency of their ligases is not high. Currently, there is a particular need to develop efficient protein-based peptide-polypeptide coupling enzymes, especially those high-efficiency ligase systems that do not require additives.
发明内容SUMMARY OF THE INVENTION
本发明基于蛋白质结构域CnaB2进行拆分,得到三组分体系谍标签(SpyTag)、BD标签(BDTag)和谍订书机酶(SpyStapler)。The invention splits the protein domain CnaB2 to obtain a three-component system spy tag (SpyTag), BD tag (BDTag) and spy stapler enzyme (SpyStapler).
进行蛋白质拆分时需要注意以下几点:(1)拆分位点需在蛋白质结构域中的柔性链或相对松散的部分;(2)拆分后的多肽或蛋白质重新识别、组装。目前主要有基于结构拆分优化的策略和基于计算模拟拆分优化的策略。对于蛋白质拆分的方法已有诸多报道和不同的应用,如对绿色荧光蛋白质的拆分、对活性蛋白质的拆分等等。这类蛋白质拆分后的基于蛋白质-蛋白质或多肽-蛋白质的相互作用重组并发挥相应的功能。这种策略已经广泛地应用在生物成像领域。然而,针对蛋白质标签的拆分报道较少。近年来发展的一系列生物偶联反应对,如谍标签(SpyTag)、K标签(KTag)和谍连接酶(SpyLigase),以及拆分蛋白质结构域RrgA得到小探标签(SnoopTagJr)、狗标签(DogTag)和探连接酶(SnoopLigase)等等。这类标签一般是长度为二十个氨基酸以内的短肽,连接酶部分则是二十个氨基酸以上分子量较大的蛋白质。这类标签能够与不同的蛋白质融合表达,环化活性蛋白质或者反应形成具有活性的蛋白质高分子链。如果能够发展一类能在生理条件下高效地反应,并且有胞内反应活性的蛋白质化学反应对,那么就能实现高效的胞内环化反应。The following points should be paid attention to when conducting protein splitting: (1) The splitting site needs to be in a flexible chain or a relatively loose part of the protein domain; (2) The split polypeptide or protein should be re-identified and assembled. At present, there are mainly strategies based on structure splitting optimization and strategies based on computing simulation splitting optimization. There have been many reports and different applications for the method of protein resolution, such as the resolution of green fluorescent protein, the resolution of active protein and so on. The protein-protein or polypeptide-protein interaction based on protein-protein or polypeptide-protein interaction recombines and exerts corresponding functions. This strategy has been widely used in the field of bioimaging. However, there are fewer reports for splitting of protein tags. A series of biological coupling reaction pairs developed in recent years, such as spy tag (SpyTag), K tag (KTag) and spy ligase (SpyLigase), as well as splitting the protein domain RrgA to obtain a small probe tag (SnoopTagJr), dog tag ( DogTag) and probe ligase (SnoopLigase) and so on. Such tags are generally short peptides with a length of less than 20 amino acids, and the ligase part is a protein with a larger molecular weight of more than 20 amino acids. Such tags can be expressed in fusion with different proteins, cyclized active proteins or reacted to form active protein polymer chains. If a class of protein-chemical reaction pairs that can react efficiently under physiological conditions and have intracellular reactivity can be developed, then efficient intracellular cyclization can be achieved.
本发明基于蛋白质结构域CnaB2进行蛋白质拆分并进行优化,得到三组分体系的多肽-多肽偶联系统,包括谍标签(SpyTag)、BD标签(BDTag)和谍订书机酶(SpyStapler),使得谍订书机酶(SpyStapler)可以催化谍标签(SpyTag)和BD标签(BDTag)之间的偶联反应,从而可以进行高效的蛋白质链中反应,通过制备含有SpyTag和BDTag两个标签的不同的融合蛋白质,实现胞内或胞外活性蛋白质(如二氢叶酸还原酶)的偶联或环化。The invention performs protein splitting and optimization based on the protein structural domain CnaB2, and obtains a polypeptide-polypeptide coupling system of a three-component system, including a spy tag (SpyTag), a BD tag (BDTag) and a spy stapler enzyme (SpyStapler), The spy stapler enzyme (SpyStapler) can catalyze the coupling reaction between the spy tag (SpyTag) and the BD tag (BDTag), so that an efficient protein chain reaction can be performed. The fusion protein can realize the coupling or cyclization of intracellular or extracellular active proteins (such as dihydrofolate reductase).
最优选的,所述谍标签(SpyTag)、BD标签(BDTag)和谍订书机酶(SpyStapler)的氨基酸序列分别如序列表中SEQ ID No:1、SEQ ID No:2和SEQ ID No:3所示。其中,对于谍订书机酶(SpyStapler)来说,相应于谍捕手第52~111位的氨基酸序列是其催化核心,例如将SEQ ID No:3中第31位的谷氨酸(E)替换为谷氨酰胺(Q)使其丧失催化SpyTag和BDTag形成异肽键的活性,而在该核心区域之外,少量氨基酸残基的缺失、增加或替换(相近性质氨基酸的替换)对催化功能的影响较小。Most preferably, the amino acid sequences of the spy tag (SpyTag), the BD tag (BDTag) and the spy stapler enzyme (SpyStapler) are respectively as SEQ ID No: 1, SEQ ID No: 2 and SEQ ID No in the sequence listing: 3 shown. Among them, for the spy stapler enzyme (SpyStapler), the amino acid sequence corresponding to positions 52 to 111 of the spy catcher is its catalytic core, for example, glutamic acid (E) at position 31 in SEQ ID No: 3 is replaced For glutamine (Q), it loses the activity of catalyzing the formation of isopeptide bonds between SpyTag and BDTag, and outside the core region, the deletion, addition or substitution of a small number of amino acid residues (the substitution of amino acids with similar properties) has a negative effect on the catalytic function. Less affected.
本发明还提供了基于上述三组分体系的多肽-多肽偶联系统的蛋白质偶联或环化方法,其实现可以发生在胞内,也可以发生在胞外,包括:The present invention also provides a protein coupling or cyclization method based on the polypeptide-polypeptide coupling system of the above-mentioned three-component system, the realization of which can occur intracellularly or extracellularly, including:
1)构建含有所述标签(SpyTag和/或BDTag)和功能蛋白质结构域的融合蛋白质的基因序列,并将其引入表达载体中;1) Construct the gene sequence of the fusion protein containing the tag (SpyTag and/or BDTag) and functional protein domain, and introduce it into the expression vector;
2)将步骤1)构建的表达载体导入细胞,在细胞中表达对应的融合蛋白质;2) Introduce the expression vector constructed in step 1) into the cell, and express the corresponding fusion protein in the cell;
3)在步骤2)的细胞内同时表达所述谍订书机酶,使融合蛋白质在胞内发生偶联或环化反应;或者,纯化步骤2)表达的融合蛋白质,使融合蛋白质和所述谍订书机酶进行胞外反应,所述谍订书机酶在胞外催化融合蛋白质发生偶联或环化反应。3) Simultaneously express the spy-stapler enzyme in the cell of step 2), so that the fusion protein undergoes a coupling or cyclization reaction in the cell; or, purify the fusion protein expressed in step 2), so that the fusion protein and the The spy stapler enzyme performs the extracellular reaction, and the spy stapler enzyme catalyzes the conjugation or cyclization of the fusion protein extracellularly.
蛋白质构筑单元中可以包括一个或者多个相同或不同的功能蛋白质结构域。标签可以位于融合蛋白质的N端、C端和蛋白质链段中。融合蛋白质可以是无序的类弹性蛋白质(Elastin-like polypeptide,ELP)或者是有序的荧光蛋白质、二氢叶酸还原酶等等,包括在医学、农业、工业、科研领域涉及的其他功能蛋白质。One or more identical or different functional protein domains may be included in a protein building block. Tags can be located at the N-terminus, C-terminus and protein segments of the fusion protein. The fusion protein can be a disordered Elastin-like polypeptide (ELP) or an ordered fluorescent protein, dihydrofolate reductase, etc., including other functional proteins involved in the fields of medicine, agriculture, industry, and scientific research.
下面通过一些具体的例子说明含蛋白质标签的构筑单元的结构:The following are some specific examples to illustrate the structure of building blocks containing protein tags:
(a)类弹性蛋白质-谍标签-类弹性蛋白质(ELP-SpyTag-ELP):从N端到C端分别为类弹性蛋白质、谍标签、类弹性蛋白质,其对应的基因序列可以是序列表中SEQ ID No:4,其中第6-11位氨基酸残基为6×His,第16-93位氨基酸残基为类弹性蛋白质,第96-105位氨基酸残基为谍标签,第108-189位氨基酸残基为类弹性蛋白质。(a) Elastin-SpyTag-Elastin (ELP-SpyTag-ELP): from the N-terminus to the C-terminus, the elastin-like protein, spy-tag, and elasto-like protein are respectively, and the corresponding gene sequences can be listed in the sequence table. SEQ ID No: 4, wherein amino acid residues 6-11 are 6×His, amino acid residues 16-93 are elastin, amino acid residues 96-105 are spy tags, and amino acid residues 108-189 The amino acid residues are elastin-like proteins.
(b)类弹性蛋白质-BD标签-类弹性蛋白质(ELP-BDTag-ELP):从N端到C端分别为类弹性蛋白质、BD标签、类弹性蛋白质,其对应的基因序列可以是序列表中SEQ ID No:5,其中第6-11位氨基酸残基为6×His,第16-93位氨基酸残基为类弹性蛋白质,第96-120位氨基酸残基为BD标签,第121-201位氨基酸残基为类弹性蛋白质。(b) Elastin-BD Tag-Elastin (ELP-BDTag-ELP): from the N-terminus to the C-terminus, the elastin-like protein, BD tag, and elastin-like protein are respectively, and the corresponding gene sequences can be listed in the sequence table. SEQ ID No: 5, wherein amino acid residues 6-11 are 6×His, amino acid residues 16-93 are elastin, amino acid residues 96-120 are BD tags, and amino acid residues 121-201 The amino acid residues are elastin-like proteins.
(c)谍标签-二氢叶酸还原酶-BD标签(SpyTag-DHFR-BDTag):从N端到C端分别为谍标签、二氢叶酸还原酶、BD标签,其对应的基因序列可以是序列表中SEQ ID No:6,其中第4-9位氨基酸残基为6×His,第22-34位氨基酸残基为谍标签,第43-227位氨基酸残基为二氢叶酸还原酶,第232-256位氨基酸残基为BD标签。(c) Spy tag-dihydrofolate reductase-BD tag (SpyTag-DHFR-BDTag): from the N-terminus to the C-terminus are spy tag, dihydrofolate reductase, BD tag, the corresponding gene sequence can be sequence SEQ ID No: 6 in the list, wherein amino acid residues 4-9 are 6×His, amino acid residues 22-34 are spy tags, amino acid residues 43-227 are dihydrofolate reductase, and amino acid residues 43-227 are dihydrofolate reductase. Amino acid residues 232-256 are BD tags.
在步骤1)中将所述谍标签和BD标签的基因分别或共同与功能蛋白质结构域的基因序列构建成融合蛋白质的基因序列,优选的,所述谍标签和BD标签的基因序列分别如序列表中 SEQ ID No:7和SEQ ID No:8所示。一般的,将谍标签和BD标签的基因构建在功能蛋白质结构域基因的两端,步骤3)在谍订书机酶的催化作用下发生环化反应。如果将谍标签和BD标签的基因分别与相同或不同的功能蛋白质结构域基因构建在一起,步骤3)在谍订书机酶的催化作用下发生相同或不同的功能蛋白质结构域之间的偶联反应。In step 1), the genes of the spy tag and the BD tag are respectively or jointly constructed with the gene sequence of the functional protein domain to form the gene sequence of the fusion protein, preferably, the gene sequences of the spy tag and the BD tag are respectively in sequence SEQ ID No: 7 and SEQ ID No: 8 are shown in the list. Generally, the genes of spy tag and BD tag are constructed at both ends of the functional protein domain gene, and step 3) cyclization reaction occurs under the catalysis of spy stapler enzyme. If the genes of spy tag and BD tag are respectively constructed with the same or different functional protein domain genes, step 3) coupling between the same or different functional protein domains occurs under the catalysis of spy stapler enzyme linked reaction.
在步骤3)中,所述谍订书机酶与融合蛋白质在胞内共表达,或者,在所述谍订书机酶的N端添加6×His标签,单独进行基因表达和纯化。优选的,所述谍订书机酶的基因如序列表中 SEQ ID No:9所示。In step 3), the spy-stapling enzyme and the fusion protein are co-expressed intracellularly, or a 6×His tag is added to the N-terminal of the spy-stapling enzyme, and gene expression and purification are performed separately. Preferably, the gene of the spy stapler enzyme is shown in SEQ ID No: 9 in the sequence listing.
对于上述步骤3)中的胞内反应产物,如果所述融合蛋白质在N端具有6×His标签,可以利用Ni亲和层析柱(如Ni-NTA树脂)对破碎的胞外溶液进行纯化,用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳表征。For the intracellular reaction product in the above step 3), if the fusion protein has a 6×His tag at the N-terminus, the broken extracellular solution can be purified using a Ni affinity chromatography column (such as Ni-NTA resin), Characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
上述步骤3)中纯化表达的蛋白质并进行胞外反应,可以将蛋白质洗脱溶液用快速流动色谱进行精纯,在生理条件下加入谍订书机酶反应,用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳表征。The protein expressed in the above step 3) is purified and subjected to extracellular reaction. The protein elution solution can be purified by fast flow chromatography, and spy-stapler enzyme reaction can be added under physiological conditions. Characterization by acrylamide gel electrophoresis.
除了类弹性蛋白质和二氢叶酸还原酶外,本发明的方法还适用于荧光蛋白质等各种蛋白质。In addition to elastin and dihydrofolate reductase, the method of the present invention is also applicable to various proteins such as fluorescent proteins.
本发明的技术主要优势在于:可以利用基因编码的方式获得纯度高且功能稳定的活性蛋白质;谍订书机酶偶联谍标签和BD标签反应效率高,且反应后部分谍订书机酶脱落,得到的环化产物的偶联部分分子量较小。本发明的蛋白质标签适用于多种功能蛋白质及可以融合表达于蛋白质的任意位置。The main advantages of the technology of the present invention are: the active protein with high purity and stable function can be obtained by means of gene coding; the reaction efficiency of the spy-stapler enzyme coupling spy-tag and the BD-tag is high, and part of the spy-stapler enzyme falls off after the reaction , the coupling part of the obtained cyclization product has a smaller molecular weight. The protein tag of the present invention is suitable for a variety of functional proteins and can be fused and expressed at any position of the protein.
附图说明Description of drawings
图1显示了体内由SpyStapler(谍订书机酶)介导的多肽-多肽(BDTag-SpyTag)偶联反应导致SpyTag-DHFR-BDTag的原位环化,其中:(a)SpyTag-DHFR-BDTag和SpyStapler胞内共表达和环化的示意图;(b)蛋白的SDS-PAGE分析结果;(c)蛋白的SEC分析结果;(d)二聚体(DHFR)2的质谱图;(e)环状蛋白c-DHFR的质谱图。Figure 1 shows the in situ cyclization of SpyTag-DHFR-BDTag by SpyStapler (spy stapler enzyme)-mediated polypeptide-polypeptide (BDTag-SpyTag) coupling reaction in vivo, where: (a) SpyTag-DHFR-BDTag Schematic diagram of intracellular co-expression and cyclization with SpyStapler; (b) SDS-PAGE analysis of protein; (c) SEC analysis of protein; (d) mass spectrogram of dimer (DHFR) 2 ; (e) ring Mass spectrum of the protein-like protein c-DHFR.
图2显示了体外由SpyStapler(谍订书机酶)介导的多肽-多肽(BDTag-SpyTag)偶联反应导致ELP-SpyTag-ELP和ELP-BDTag-ELP的偶联形成四臂星型化合物,其中: (a) 偶联反应的示意图;(b)蛋白SDS-PAGE分析结果;(c)蛋白SEC分析结果;(d)原料反应物蛋白的质谱;(e)反应产物四臂星型ELP的质谱。Figure 2 shows that the SpyStapler (spy stapler enzyme)-mediated peptide-polypeptide (BDTag-SpyTag) coupling reaction in vitro results in the coupling of ELP-SpyTag-ELP and ELP-BDTag-ELP to form a four-armed star compound, Among them: (a) schematic diagram of coupling reaction; (b) protein SDS-PAGE analysis result; (c) protein SEC analysis result; (d) mass spectrum of raw material reactant protein; (e) four-arm star ELP of reaction product mass spectrometry.
图3显示了体外由SpyStapler(谍订书机酶)介导的多肽-多肽(BDTag-SpyTag)偶联反应导致SpyTag-DHFR-BDTag发生环化,其中: (a) SpyTag-DHFR-BDTag胞外环化反应的示意图;(b)蛋白SDS-PAGE分析结果;(c)蛋白SEC分析结果;(d)原料反应物蛋白的质谱;(e)反应产物的质谱。Figure 3 shows that SpyStapler (spy stapler enzyme)-mediated polypeptide-polypeptide (BDTag-SpyTag) coupling reaction in vitro results in the cyclization of SpyTag-DHFR-BDTag, where: (a) SpyTag-DHFR-BDTag extracellular Schematic diagram of the cyclization reaction; (b) protein SDS-PAGE analysis result; (c) protein SEC analysis result; (d) mass spectrum of raw reactant protein; (e) mass spectrum of reaction product.
具体实施方式Detailed ways
下面通过实施例进一步对本发明进行详细说明,但不以任何方式限制本发明的范围。The present invention will be further described in detail through the following examples, but the scope of the present invention is not limited in any way.
制备含有蛋白质标签的融合蛋白质具体步骤:通过重组基因工程技术构建含有6×His标签(用于蛋白质纯化)、谍标签(SpyTag)、BD标签(BDTag)、类弹性蛋白质(ELP)、二氢叶酸还原酶(DHFR)的融合蛋白质,即ELP-SpyTag-ELP、ELP-BDTag-ELP、SpyTag-DHFR-BDTag的基因序列并插入表达载体中,用分子克隆技术将表达载体转化到大肠杆菌中表达,再通过亲和层析等一系列蛋白质纯化方法得到目标融合蛋白质。所述融合蛋白质有ELP-SpyTag-ELP、ELP-BDTag-ELP、SpyTag-DHFR-BDTag。Specific steps for preparing fusion protein containing protein tag: constructing a fusion protein containing 6×His tag (for protein purification), spy tag (SpyTag), BD tag (BDTag), elastin-like protein (ELP), dihydrofolate by recombinant genetic engineering technology The fusion protein of reductase (DHFR), namely the gene sequence of ELP-SpyTag-ELP, ELP-BDTag-ELP, SpyTag-DHFR-BDTag, was inserted into the expression vector, and the expression vector was transformed into E. coli for expression by molecular cloning technology. The target fusion protein is obtained by a series of protein purification methods such as affinity chromatography. The fusion proteins include ELP-SpyTag-ELP, ELP-BDTag-ELP, SpyTag-DHFR-BDTag.
利用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)、尺寸排阻色谱(SEC)、基质辅助激光解析电离-时间飞行质谱(MALDI-TOF)、液相色谱-超高效液相色谱(LC-MS)等方法表征融合蛋白质及其反应产物的分子量、拓扑结构等性质。Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), size exclusion chromatography (SEC), matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF), liquid chromatography-ultra performance liquid Liquid chromatography (LC-MS) and other methods were used to characterize the molecular weight, topology and other properties of fusion proteins and their reaction products.
实施例1:融合蛋白质目的基因的转化与表达Example 1: Transformation and expression of fusion protein target gene
构建pQE-80 L ELP-SpyTag-ELP、pQE-80 L ELP-BDTag-ELP的质粒,经测序确认后转入BL21(DE3)感受态细胞中并涂板,在培养箱中过夜37 oC培养。在平板上挑出单克隆菌落至含有0.10 mg/mL氨苄青霉素钠的LB培养基中,在震荡培养箱中37 oC培养过夜。取过夜培养的培养基按1∶100比例加入含有0.10 mg/mL的氨苄青霉素钠1 L LB培养基中,在37 oC震荡培养至OD600为0.4-0.6,加入异丙基-β-D-硫代吡喃半乳糖苷(IPTG)至终浓度为1 mM诱导大肠杆菌表达蛋白质。振荡培养箱温度改为30 oC培养。The plasmids of pQE-80 L ELP-SpyTag-ELP and pQE-80 L ELP-BDTag-ELP were constructed, confirmed by sequencing, transferred into BL21(DE3) competent cells and plated, and cultured in an incubator overnight at 37 o C . Pick out monoclonal colonies on the plate into LB medium containing 0.10 mg/mL ampicillin sodium and incubate overnight at 37 o C in a shaking incubator. Take the medium from the overnight culture and add it to 1 L LB medium containing 0.10 mg/mL ampicillin sodium at a ratio of 1:100, shake it at 37 o C and culture it to an OD 600 of 0.4-0.6, add isopropyl-β-D - Thiogalactopyranoside (IPTG) to a final concentration of 1 mM to induce protein expression in E. coli. Change the temperature of the shaking incubator to 30 o C.
构建pACYCDuet-1 SpyTag-DHFR-BDTag (MCS1)-SpyStapler (MCS2)的质粒,经测序确认后转入BL21(DE3)感受态细胞中并涂板,在培养箱中过夜37 oC培养。在平板上挑出单克隆菌落至含有0.50 mg/mL氯霉素的LB培养基中,在震荡培养箱中37 oC培养过夜。取过夜培养的培养基按1∶100比例加入含有0.50 mg/mL的氯霉素1 L LB培养基中,在37 oC震荡培养至OD600为0.4-0.6,加入异丙基-β-D-硫代吡喃半乳糖苷(IPTG)至终浓度为1 mM诱导大肠杆菌表达蛋白质。振荡培养箱温度改为16 oC过夜培养。The plasmid pACYCDuet-1 SpyTag-DHFR-BDTag (MCS1)-SpyStapler (MCS2) was constructed, confirmed by sequencing, transferred into BL21 (DE3) competent cells and plated, and cultured in an incubator overnight at 37 o C. Pick out monoclonal colonies on the plate into LB medium containing 0.50 mg/mL chloramphenicol, and cultivate overnight at 37 o C in a shaking incubator. Take the medium from the overnight culture and add it to 1 L LB medium containing 0.50 mg/mL chloramphenicol at a ratio of 1:100, shake it at 37 o C and culture it to an OD 600 of 0.4-0.6, add isopropyl-β-D - Thiogalactopyranoside (IPTG) to a final concentration of 1 mM to induce protein expression in E. coli. The shaking incubator temperature was changed to 16 o C for overnight incubation.
实施例2:融合蛋白质的纯化Example 2: Purification of fusion proteins
表达结束以后,4000 g转速高速离心20分钟收集菌体,舍去上清液。对于用自然条件纯化的蛋白质谍订书机酶(SpyStapler)、谍订书机酶突变体(SpyStapler-EQ)和融合蛋白质SpyTag-DHFR-BDTag,用非变性缓冲液A(20 mM 磷酸二氢钠,300 mM 氯化钠,10 mM 咪唑,pH = 8.0)重悬。重悬液在4 oC冰水浴条件下超声破碎20分钟(工作5秒钟,间隔5秒钟,强度40 %)。在4 oC条件下,破碎溶液用高速落地离心机用20000 g离心20分钟,保留裂解上清液。将上清液与平衡好的亲和树脂Ni-NTA树脂混合,在4 oC旋转均匀混合1小时。混合液倒入空柱,等待树脂均匀沉降,舍弃裂解液。用自然缓冲液B(50 mM 磷酸二氢钠, 300 mM氯化钠,20 mM 咪唑,pH = 8.0)冲洗目的蛋白质,再用自然缓冲液C(50 mM 磷酸二氢钠,300 mM 氯化钠,250 mM 咪唑,pH = 8.0)洗脱目的蛋白质。收集的目的蛋白质并使用超滤管浓缩,得到的浓缩液在4 oC条件下经过蛋白质快速纯化系统纯化。After the expression, the cells were collected by high-speed centrifugation at 4000 g for 20 minutes, and the supernatant was discarded. For protein spy-staplerase (SpyStapler), spy-staplerase mutant (SpyStapler-EQ) and fusion protein SpyTag-DHFR-BDTag purified by native conditions, use native buffer A (20 mM sodium dihydrogen phosphate) , 300 mM NaCl, 10 mM imidazole, pH = 8.0). The resuspension was sonicated for 20 minutes in a 4 o C ice-water bath (5 sec work, 5 sec interval, 40% intensity). The disrupted solution was centrifuged at 20,000 g for 20 minutes in a high-speed floor-standing centrifuge at 4 o C, and the lysed supernatant was retained. The supernatant was mixed with the equilibrated affinity resin Ni-NTA resin, and the mixture was uniformly mixed by rotating at 4 o C for 1 hour. Pour the mixture into the empty column, wait for the resin to settle evenly, and discard the lysate. Rinse the protein of interest with native buffer B (50 mM sodium dihydrogen phosphate, 300 mM sodium chloride, 20 mM imidazole, pH = 8.0) followed by native buffer C (50 mM sodium dihydrogen phosphate, 300 mM sodium chloride) , 250 mM imidazole, pH = 8.0) to elute the target protein. The collected target protein is concentrated using an ultrafiltration tube, and the obtained concentrate is purified by a protein rapid purification system at 4 o C.
对于用变性条件纯化的蛋白质ELP-SpyTag-ELP、ELP-BDTag-ELP,用变性缓冲液A(20 mM 磷酸二氢钠,300 mM 氯化钠,10 mM 咪唑,8 M 尿素,pH = 8.0)重悬。重悬液在4oC冰水浴条件下超声破碎20分钟(工作5秒钟,间隔5秒钟,强度40 %)。在4 oC条件下,破碎溶液用高速落地离心机用20000 g离心20分钟,保留裂解上清液。将上清液与平衡好的亲和树脂Ni-NTA树脂混合,在4 oC旋转均匀混合1小时。混合液倒入空柱,等待树脂均匀沉降,舍弃裂解液。用自然缓冲液B(50 mM 磷酸二氢钠,300 mM 氯化钠,20 mM 咪唑,8 M 尿素,pH =8.0)冲洗目的蛋白质,再用自然缓冲液C(50 mM 磷酸二氢钠,300 mM 氯化钠,250 mM 咪唑,8 M 尿素,pH = 4.0)洗脱目的蛋白质。收集的目的蛋白质并使用超滤管浓缩,得到的浓缩液在4 oC条件下经过蛋白质快速纯化系统纯化。For proteins ELP-SpyTag-ELP, ELP-BDTag-ELP purified with denaturing conditions, use denaturing buffer A (20 mM sodium dihydrogen phosphate, 300 mM NaCl, 10 mM imidazole, 8 M urea, pH = 8.0) Resuspended. The resuspension was sonicated for 20 minutes in a 4 o C ice-water bath (5 sec work, 5 sec interval, 40% intensity). The disrupted solution was centrifuged at 20,000 g for 20 minutes in a high-speed floor-standing centrifuge at 4 o C, and the lysed supernatant was retained. The supernatant was mixed with the equilibrated affinity resin Ni-NTA resin, and the mixture was uniformly mixed by rotating at 4 o C for 1 hour. Pour the mixture into the empty column, wait for the resin to settle evenly, and discard the lysate. Rinse the protein of interest with natural buffer B (50 mM sodium dihydrogen phosphate, 300 mM sodium chloride, 20 mM imidazole, 8 M urea, pH = 8.0), followed by natural buffer C (50 mM sodium dihydrogen phosphate, 300 mM urea). mM NaCl, 250 mM imidazole, 8 M urea, pH = 4.0) to elute the protein of interest. The collected target protein is concentrated using an ultrafiltration tube, and the obtained concentrate is purified by a protein rapid purification system at 4 o C.
实施例3:融合蛋白质的表征Example 3: Characterization of fusion proteins
1 mL的蛋白质洗脱液在AKTA蛋白纯化系统(AKTA Avant,GE Healthcare)上经过凝胶渗透柱Superdex 200 Increase 10/300 GL进行精纯。流动相为PBS,流速为0.5 mL/min。通过监测A280收集目标峰。1 mL of the protein eluate was purified on a gel permeation column Superdex 200
纯化产物的分子量用基质辅助激光解吸电离-飞行时间质谱(MALDI-TOF)或高效液相色谱-电喷雾质谱(LC-MS)来测定,所用仪器为 5800 MALDI-TOF/TOF 分析仪(ABSCIEX)。结果如图1所示,体内由SpyStapler(谍订书机酶)介导的多肽-多肽(BDTag-SpyTag)偶联反应导致SpyTag-DHFR-BDTag的原位环化。The molecular weight of the purified product was determined by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF) or high performance liquid chromatography-electrospray mass spectrometry (LC-MS) using a 5800 MALDI-TOF/TOF analyzer (ABSCIEX) . The results are shown in Figure 1. In vivo SpyStapler-mediated polypeptide-polypeptide (BDTag-SpyTag) coupling reaction resulted in in situ cyclization of SpyTag-DHFR-BDTag.
实施例4:融合蛋白质的胞内反应与表征Example 4: Intracellular responses and characterization of fusion proteins
根据蛋白质快速纯化系统的纯化结果,取流出体积8 mL和流出体积12 mL 样品各20 μL,加入5×上样缓冲液并置于基因扩增仪煮沸,停止反应。取20 μL蛋白质洗脱溶液加入5×上样缓冲液并置于基因扩增仪煮沸。对照组取终浓度为线性的SpyTag-DHFR-BDTag并加入5×上样缓冲液并置于基因扩增仪煮沸。用聚丙烯酰胺凝胶电泳表征蛋白质,用多功能荧光分析仪定量蛋白质的反应物和产物,结果见图1。当SpyTag-DHFR-BDTag和SpyStapler在胞内共表达时,由SpyStapler(谍订书机酶)介导的多肽-多肽(BDTag-SpyTag)偶联反应导致SpyTag-DHFR-BDTag发生原位环化。According to the purification results of the protein rapid purification system, take 20 μL of the 8 mL outflow volume and 12 mL outflow volume sample, add 5× loading buffer and place it in the gene amplification instrument to boil to stop the reaction. Add 20 μL of protein elution solution to 5× loading buffer and place it in the gene amplification instrument to boil. In the control group, SpyTag-DHFR-BDTag with a final concentration of linearity was taken and added with 5× loading buffer and placed in a gene amplification apparatus to boil. The protein was characterized by polyacrylamide gel electrophoresis, and the reactants and products of the protein were quantified by a multifunctional fluorescence analyzer. The results are shown in Figure 1. When SpyTag-DHFR-BDTag and SpyStapler were co-expressed intracellularly, a polypeptide-polypeptide (BDTag-SpyTag) coupling reaction mediated by SpyStapler (spy stapler enzyme) resulted in in situ cyclization of SpyTag-DHFR-BDTag.
实施例5:融合蛋白质的胞外反应与表征Example 5: Extracellular responses and characterization of fusion proteins
用超微量分光光度计(P330,Implen)测量ELP-SpyTag-ELP、ELP-BDTag-ELP、SpyStapler、SpyStapler-EQ的浓度。各取ELP-SpyTag-ELP、ELP-BDTag-ELP至体系中蛋白质终浓度为10 μM,SpyStapler或者SpyStapler-EQ的终浓度为30 μM。加入1×PBS(pH=7.4)至体积为20 μL,置于基因扩增仪 4 oC培养8小时。对于含有N-氧化三甲胺(TMAO)的实验组,TMAO的终浓度为1.5 M,到达反应时间后加入5×上样缓冲液并置于基因扩增仪煮沸,停止反应。用聚丙烯酰胺凝胶电泳表征蛋白质,用多功能荧光分析仪定量蛋白质的反应物和产物。其结果如图2所示,由SpyStapler(谍订书机酶)介导的多肽-多肽(BDTag-SpyTag)偶联反应导致ELP-SpyTag-ELP和ELP-BDTag-ELP的偶联形成四臂星型化合物。The concentrations of ELP-SpyTag-ELP, ELP-BDTag-ELP, SpyStapler, SpyStapler-EQ were measured with an ultra-micro spectrophotometer (P330, Implen). Take ELP-SpyTag-ELP and ELP-BDTag-ELP to the final protein concentration of 10 μM in the system, and the final concentration of SpyStapler or SpyStapler-EQ is 30 μM. Add 1×PBS (pH=7.4) to a volume of 20 μL, place in a gene amplification apparatus and incubate at 4 o C for 8 hours. For the experimental group containing N-trimethylamine oxide (TMAO), the final concentration of TMAO was 1.5 M. After reaching the reaction time, 5× loading buffer was added and placed in a gene amplification instrument to boil to stop the reaction. The protein was characterized by polyacrylamide gel electrophoresis, and the reactants and products of the protein were quantified by a multifunctional fluorescence analyzer. The results are shown in Figure 2. The SpyStapler (spy stapler enzyme)-mediated polypeptide-polypeptide (BDTag-SpyTag) coupling reaction resulted in the coupling of ELP-SpyTag-ELP and ELP-BDTag-ELP to form a four-armed star. type compound.
实施例6:融合蛋白质的胞外反应与表征Example 6: Extracellular responses and characterization of fusion proteins
用超微量分光光度计(P330,Implen)测量SpyTag-DHFR-BDTag、SpyStapler的浓度。取SpyTag-DHFR-BDTag至体系终浓度为10 μM,SpyStapler的终浓度为20 μM。加入1×PBS(pH=7.4)至体积为20 μL,置于基因扩增仪 4 oC培养8小时。到达反应时间后加入5×上样缓冲液并置于基因扩增仪煮沸,停止反应。用聚丙烯酰胺凝胶电泳表征蛋白质,用多功能荧光分析仪定量蛋白质的反应物和产物。其结果如图3所示,由SpyStapler(谍订书机酶)介导的活性蛋白质二氢叶酸还原酶胞外环化反应得到环化和二聚的二氢叶酸还原酶。The concentrations of SpyTag-DHFR-BDTag and SpyStapler were measured with an ultra-micro spectrophotometer (P330, Implen). Take SpyTag-DHFR-BDTag to the final concentration of 10 μM in the system, and the final concentration of SpyStapler to 20 μM. Add 1×PBS (pH=7.4) to a volume of 20 μL, place in a gene amplification apparatus and incubate at 4 o C for 8 hours. After reaching the reaction time, add 5× sample buffer and place it in the gene amplification instrument to boil to stop the reaction. The protein was characterized by polyacrylamide gel electrophoresis, and the reactants and products of the protein were quantified by a multifunctional fluorescence analyzer. As a result, as shown in Fig. 3, the cyclized and dimerized dihydrofolate reductase was obtained by the extracellular cyclization of active protein dihydrofolate reductase mediated by SpyStapler (spy stapler enzyme).
SEQUENCE LISTINGSEQUENCE LISTING
<110> 北京大学<110> Peking University
<120> 一种基于无序蛋白偶联酶的高效多肽-多肽偶联系统和方法<120> A high-efficiency peptide-polypeptide coupling system and method based on disordered protein coupling enzyme
<130> WX2019-03-166<130> WX2019-03-166
<150> CN2018112219357<150> CN2018112219357
<151> 2018-10-19<151> 2018-10-19
<160> 9<160> 9
<170> PatentIn version 3.5<170> PatentIn version 3.5
<210> 1<210> 1
<211> 13<211> 13
<212> PRT<212> PRT
<213> 人工序列<213> Artificial sequences
<400> 1<400> 1
Ala His Ile Val Met Val Asp Ala Tyr Lys Pro Thr LysAla His Ile Val Met Val Asp Ala Tyr Lys Pro Thr Lys
1 5 101 5 10
<210> 2<210> 2
<211> 25<211> 25
<212> PRT<212> PRT
<213> 人工序列<213> Artificial sequences
<400> 2<400> 2
Ala Thr His Ile Lys Phe Ser Lys Arg Asp Glu Asp Gly Lys Glu LeuAla Thr His Ile Lys Phe Ser Lys Arg Asp Glu Asp Gly Lys Glu Leu
1 5 10 151 5 10 15
Ala Gly Ala Thr Met Glu Leu Arg AspAla Gly Ala Thr Met Glu Leu Arg Asp
20 25 20 25
<210> 3<210> 3
<211> 64<211> 64
<212> PRT<212> PRT
<213> 人工序列<213> Artificial sequences
<400> 3<400> 3
Val Glu Ala Ser Gly Lys Thr Ile Ser Thr Trp Ile Ser Asp Gly GlnVal Glu Ala Ser Gly Lys Thr Ile Ser Thr Trp Ile Ser Asp Gly Gln
1 5 10 151 5 10 15
Val Lys Asp Phe Tyr Leu Tyr Pro Gly Lys Tyr Thr Phe Val Glu ThrVal Lys Asp Phe Tyr Leu Tyr Pro Gly Lys Tyr Thr Phe Val Glu Thr
20 25 30 20 25 30
Ala Ala Pro Asp Gly Tyr Glu Val Ala Thr Ala Ile Thr Phe Thr ValAla Ala Pro Asp Gly Tyr Glu Val Ala Thr Ala Ile Thr Phe Thr Val
35 40 45 35 40 45
Asn Glu Gln Gly Gln Val Thr Val Asn Gly Lys Ala Thr Lys Gly GlyAsn Glu Gln Gly Gln Val Thr Val Asn Gly Lys Ala Thr Lys Gly Gly
50 55 60 50 55 60
<210> 4<210> 4
<211> 205<211> 205
<212> PRT<212> PRT
<213> 人工序列<213> Artificial sequences
<400> 4<400> 4
Met Lys Gly Ser Ser His His His His His His Val Asp Gly His GlyMet Lys Gly Ser Ser His His His His His His Val Asp Gly His Gly
1 5 10 151 5 10 15
Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly GluVal Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Glu
20 25 30 20 25 30
Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val GlyGly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly
35 40 45 35 40 45
Val Pro Gly Val Gly Val Pro Gly Glu Gly Val Pro Gly Val Gly ValVal Pro Gly Val Gly Val Pro Gly Glu Gly Val Pro Gly Val Gly Val
50 55 60 50 55 60
Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val ProPro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
65 70 75 8065 70 75 80
Gly Glu Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Glu Leu AlaGly Glu Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Glu Leu Ala
85 90 95 85 90 95
His Ile Val Met Val Asp Ala Tyr Lys Pro Thr Lys Thr Ser Val ProHis Ile Val Met Val Asp Ala Tyr Lys Pro Thr Lys Thr Ser Val Pro
100 105 110 100 105 110
Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Glu Gly Val Pro GlyGly Val Gly Val Pro Gly Val Gly Val Pro Gly Glu Gly Val Pro Gly
115 120 125 115 120 125
Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly ValVal Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
130 135 140 130 135 140
Gly Val Pro Gly Glu Gly Val Pro Gly Val Gly Val Pro Gly Val GlyGly Val Pro Gly Glu Gly Val Pro Gly Val Gly Val Pro Gly Val Gly
145 150 155 160145 150 155 160
Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Glu Gly ValVal Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Glu Gly Val
165 170 175 165 170 175
Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Gly Leu Leu AspPro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Gly Leu Leu Asp
180 185 190 180 185 190
Gly Pro Gln Gly Ile Trp Gly Gln Leu Glu Lys Lys MetGly Pro Gln Gly Ile Trp Gly Gln Leu Glu Lys Lys Met
195 200 205 195 200 205
<210> 5<210> 5
<211> 217<211> 217
<212> PRT<212> PRT
<213> 人工序列<213> Artificial sequences
<400> 5<400> 5
Met Lys Gly Ser Ser His His His His His His Val Asp Gly His GlyMet Lys Gly Ser Ser His His His His His His Val Asp Gly His Gly
1 5 10 151 5 10 15
Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly GluVal Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Glu
20 25 30 20 25 30
Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val GlyGly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly
35 40 45 35 40 45
Val Pro Gly Val Gly Val Pro Gly Glu Gly Val Pro Gly Val Gly ValVal Pro Gly Val Gly Val Pro Gly Glu Gly Val Pro Gly Val Gly Val
50 55 60 50 55 60
Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val ProPro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro
65 70 75 8065 70 75 80
Gly Glu Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Glu Leu AlaGly Glu Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Glu Leu Ala
85 90 95 85 90 95
Thr His Ile Lys Phe Ser Lys Arg Asp Glu Asp Gly Lys Glu Leu AlaThr His Ile Lys Phe Ser Lys Arg Asp Glu Asp Gly Lys Glu Leu Ala
100 105 110 100 105 110
Gly Ala Thr Met Glu Leu Arg Asp Thr Ser Val Pro Gly Val Gly ValGly Ala Thr Met Glu Leu Arg Asp Thr Ser Val Pro Gly Val Gly Val
115 120 125 115 120 125
Pro Gly Val Gly Val Pro Gly Glu Gly Val Pro Gly Val Gly Val ProPro Gly Val Gly Val Pro Gly Glu Gly Val Pro Gly Val Gly Val Pro
130 135 140 130 135 140
Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro GlyGly Val Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly
145 150 155 160145 150 155 160
Glu Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly ValGlu Gly Val Pro Gly Val Gly Val Pro Gly Val Gly Val Pro Gly Val
165 170 175 165 170 175
Gly Val Pro Gly Val Gly Val Pro Gly Glu Gly Val Pro Gly Val GlyGly Val Pro Gly Val Gly Val Pro Gly Glu Gly Val Pro Gly Val Gly
180 185 190 180 185 190
Val Pro Gly Val Gly Val Pro Gly Gly Leu Leu Asp Gly Pro Gln GlyVal Pro Gly Val Gly Val Pro Gly Gly Leu Leu Asp Gly Pro Gln Gly
195 200 205 195 200 205
Ile Trp Gly Gln Leu Glu Lys Lys MetIle Trp Gly Gln Leu Glu Lys Lys Met
210 215 210 215
<210> 6<210> 6
<211> 256<211> 256
<212> PRT<212> PRT
<213> 人工序列<213> Artificial sequences
<400> 6<400> 6
Gly Ser Ser His His His His His His Ser Ser Gly Leu Val Pro ArgGly Ser Ser His His His His His His Ser Ser Gly Leu Val Pro Arg
1 5 10 151 5 10 15
Gly Ser His Met Gly Ala His Ile Val Met Val Asp Ala Tyr Lys ProGly Ser His Met Gly Ala His Ile Val Met Val Asp Ala Tyr Lys Pro
20 25 30 20 25 30
Thr Lys Gly Ser Gly Gly Ser Gly Met Ile Ser Leu Ile Ala Ala LeuThr Lys Gly Ser Gly Gly Ser Gly Met Ile Ser Leu Ile Ala Ala Leu
35 40 45 35 40 45
Ala Val Asp Arg Val Ile Gly Met Glu Asn Ala Met Pro Trp Asn LeuAla Val Asp Arg Val Ile Gly Met Glu Asn Ala Met Pro Trp Asn Leu
50 55 60 50 55 60
Pro Ala Asp Leu Ala Trp Phe Lys Arg Asn Thr Leu Asn Lys Pro ValPro Ala Asp Leu Ala Trp Phe Lys Arg Asn Thr Leu Asn Lys Pro Val
65 70 75 8065 70 75 80
Ile Met Gly Arg His Thr Trp Glu Ser Ile Gly Arg Pro Leu Pro GlyIle Met Gly Arg His Thr Trp Glu Ser Ile Gly Arg Pro Leu Pro Gly
85 90 95 85 90 95
Arg Lys Asn Ile Ile Leu Ser Ser Gln Pro Gly Thr Asp Asp Arg ValArg Lys Asn Ile Ile Leu Ser Ser Gln Pro Gly Thr Asp Asp Arg Val
100 105 110 100 105 110
Thr Trp Val Lys Ser Val Asp Glu Ala Ile Ala Ala Cys Gly Asp ValThr Trp Val Lys Ser Val Asp Glu Ala Ile Ala Ala Cys Gly Asp Val
115 120 125 115 120 125
Pro Glu Ile Met Val Ile Gly Gly Gly Arg Val Tyr Glu Gln Phe LeuPro Glu Ile Met Val Ile Gly Gly Gly Arg Val Tyr Glu Gln Phe Leu
130 135 140 130 135 140
Pro Lys Ala Gln Lys Leu Tyr Leu Thr His Ile Asp Ala Glu Val GluPro Lys Ala Gln Lys Leu Tyr Leu Thr His Ile Asp Ala Glu Val Glu
145 150 155 160145 150 155 160
Gly Asp Thr His Phe Pro Asp Tyr Glu Pro Asp Asp Trp Glu Ser ValGly Asp Thr His Phe Pro Asp Tyr Glu Pro Asp Asp Trp Glu Ser Val
165 170 175 165 170 175
Phe Ser Glu Phe His Asp Ala Asp Ala Gln Asn Ser His Ser Tyr CysPhe Ser Glu Phe His Asp Ala Asp Ala Gln Asn Ser His Ser Tyr Cys
180 185 190 180 185 190
Phe Glu Ile Leu Glu Arg Arg Gly Ser Gly Gly Ser Gly Gly Ala MetPhe Glu Ile Leu Glu Arg Arg Gly Ser Gly Gly Ser Gly Gly Ala Met
195 200 205 195 200 205
Val Asp Thr Leu Ser Gly Leu Ser Ser Glu Gln Gly Gln Ser Gly AspVal Asp Thr Leu Ser Gly Leu Ser Ser Glu Gln Gly Gln Ser Gly Asp
210 215 220 210 215 220
Met Thr Ile Glu Glu Asp Ser Ala Thr His Ile Lys Phe Ser Lys ArgMet Thr Ile Glu Glu Asp Ser Ala Thr His Ile Lys Phe Ser Lys Arg
225 230 235 240225 230 235 240
Asp Glu Asp Gly Lys Glu Leu Ala Gly Ala Thr Met Glu Leu Arg AspAsp Glu Asp Gly Lys Glu Leu Ala Gly Ala Thr Met Glu Leu Arg Asp
245 250 255 245 250 255
<210> 7<210> 7
<211> 39<211> 39
<212> DNA<212> DNA
<213> 人工序列<213> Artificial sequences
<400> 7<400> 7
gcccacatcg tgatggtgga cgcctacaag ccgacgaag 39gcccacatcg tgatggtgga cgcctacaag ccgacgaag 39
<210> 8<210> 8
<211> 75<211> 75
<212> DNA<212> DNA
<213> 人工序列<213> Artificial sequences
<400> 8<400> 8
gctacccata ttaaattctc aaaacgtgat gaggacggca aagagttagc tggtgcaact 60gctacccata ttaaattctc aaaacgtgat gaggacggca aagagttagc tggtgcaact 60
atggagttgc gtgat 75atggagttgc gtgat 75
<210> 9<210> 9
<211> 192<211> 192
<212> DNA<212> DNA
<213> 人工序列<213> Artificial sequences
<400> 9<400> 9
gtcgaggcta gcggtaaaac tattagtaca tggatttcag atggacaagt gaaagatttc 60gtcgaggcta gcggtaaaac tattagtaca tggatttcag atggacaagt gaaagatttc 60
tacctgtatc caggaaaata tacatttgtc gaaaccgcag caccagacgg ttatgaggta 120tacctgtatc caggaaaata tacatttgtc gaaaccgcag caccagacgg ttatgaggta 120
gcaactgcta ttacctttac agttaatgag caaggtcagg ttactgtaaa tggcaaagca 180gcaactgcta ttacctttac agttaatgag caaggtcagg ttactgtaaa tggcaaagca 180
actaaaggtg gc 192actaaaggtg gc 192
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811221935 | 2018-10-19 | ||
CN2018112219357 | 2018-10-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111073925A CN111073925A (en) | 2020-04-28 |
CN111073925B true CN111073925B (en) | 2022-04-26 |
Family
ID=70310587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910995483.6A Active CN111073925B (en) | 2018-10-19 | 2019-10-18 | High-efficiency polypeptide-polypeptide coupling system and method based on disordered protein coupling enzyme |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111073925B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111560391B (en) * | 2020-05-21 | 2022-02-11 | 北京大学 | Biosynthesis method of protein heterogeneous catenane |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105061581A (en) * | 2015-09-17 | 2015-11-18 | 北京大学 | Preparation method for genetically coded holoprotein catenane |
CN106591345A (en) * | 2016-12-26 | 2017-04-26 | 华侨大学 | Method for separation and purification and immobilization integration of recombinant double enzyme |
CN108026148A (en) * | 2015-06-05 | 2018-05-11 | 牛津大学创新有限公司 | Fusion protein synthetic method and product |
-
2019
- 2019-10-18 CN CN201910995483.6A patent/CN111073925B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108026148A (en) * | 2015-06-05 | 2018-05-11 | 牛津大学创新有限公司 | Fusion protein synthetic method and product |
CN105061581A (en) * | 2015-09-17 | 2015-11-18 | 北京大学 | Preparation method for genetically coded holoprotein catenane |
CN106591345A (en) * | 2016-12-26 | 2017-04-26 | 华侨大学 | Method for separation and purification and immobilization integration of recombinant double enzyme |
Non-Patent Citations (3)
Title |
---|
《An intrinsically disordered peptide-peptide stapler for highly efficient protein ligation both in vivo and in vitro》;Xia-Ling Wu等;《Journal of the American Chemical Society》;20181204;第140卷(第50期);第17474-17483页 * |
《Controlling macromolecular topology with genetically encoded SpyTag-SpyCatcher chemistry》;Wen-Bin Zhang等;《Journal of the American Chemical Society》;20130909;第135卷(第37期);第13988-13997页 * |
《可基因编码的多肽-蛋白质化学反应对》;方晶等;《高分子学报》;20180322(第4期);第429-444页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111073925A (en) | 2020-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2583009C (en) | Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography | |
JP6883529B2 (en) | Methods and products for synthesizing fusion proteins | |
CN108884154A (en) | Split intein with unique splicing activity | |
US12030913B2 (en) | Bacterial colicin-immunity protein protein purification system | |
US20130053544A1 (en) | Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds | |
CN106497897A (en) | A kind of engineered strain construction method for improving Heparinase I activity | |
US20120322733A1 (en) | Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases | |
CN102643847A (en) | Polygene coexpression system and production method containing disulfide-bond functional protein | |
CN111073925B (en) | High-efficiency polypeptide-polypeptide coupling system and method based on disordered protein coupling enzyme | |
WO2020249723A1 (en) | Cysteine-free inteins | |
JP5865002B2 (en) | Recombinant plasmid vector and protein production method using the same | |
US20160319287A1 (en) | Atypical inteins | |
JP2016518855A (en) | Fusion protease | |
CN113045633A (en) | Design of protein heterogeneous entanglement primitive and preparation method of complex catenane structure | |
MA | High expression level of human epidermal growth factor (hEGF) using a well-designed fusion protein-tagged construct in E. coli. | |
Lu et al. | Optimized procedures for producing biologically active chemokines | |
Baumann et al. | Identification of a potential modification site in human stromal cell‐derived factor‐1 | |
CN110724202A (en) | ADAMTS13 substrate with histidine tag as well as preparation method and application thereof | |
Chilakapati et al. | Characterization and expression profiling of recombinant parathyroid hormone (rhPTH) analog 1–34 in Escherichia coli, precise with enhanced biological activity | |
WO2024119434A1 (en) | Solubilization-assisting short peptide tag with acidic surface for improving expression efficiency of recombinant protein | |
CN112689674B (en) | Dextran affinity tags and their applications | |
KR20200008147A (en) | Method of Making Refolded Recombinant Humanized Ranibizumab | |
WO2004031243A1 (en) | Protein polymer and process for producing the same | |
EP4079845A1 (en) | Method for enhancing water solubility of target protein by whep domain fusion | |
CN119082159A (en) | A plasmid vector and a method for simultaneously displaying two polypeptides or proteins on the surface of MS2-VLP |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |